Business Context and Reporting Period
This Form 8-K reports on events occurring at the 2018 Annual Meeting of Stockholders of Rocket Pharmaceuticals, Inc., held on June 25, 2018. The filing details corporate governance changes, director elections, and the approval of equity incentive plans.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
- Board Structure: Stockholders approved the "Declassification Amendment," eliminating the classified Board structure to provide for the annual election of directors.
- Director Removal: Stockholders approved the "Director Removal Amendment," replacing the supermajority voting requirement for director removal with a majority voting standard.
- Director Elections: Following the declassification, seven directors were elected to one-year terms until the 2019 annual meeting. All nominees received the highest number of "For" votes.
- Equity Plan: Stockholders approved the Second Amended and Restated 2014 Stock Option and Incentive Plan.
- Accounting Firm: The appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2018, was ratified.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies. The document serves as a current report of completed corporate actions.
Key Facts for Investor Verification
- Voting Participation: Approximately 97.54% of shares entitled to vote (38,503,328 of 39,472,907) were represented at the meeting.
- Proposal 6 Opposition: While approved, the 2014 Stock Option and Incentive Plan received significant opposition, with 4,346,976 votes cast against the proposal compared to 30,877,179 votes in favor.
- Director Vote Distribution: Naveen Yalamanchi, M.D., received the highest number of "Withheld" votes (2,152,657) among the seven elected directors, though he was still elected.
- Broker Non-Votes: There were 3,277,999 broker non-votes recorded across the proposals.